News

PV-10 is a new oncology drug that selectively targets and destroys cancer cells without harming surrounding healthy tissue, thereby reducing potential for systemic side effects. The data titled

Eric Smart has also worked as executive vice president and was in-charge of business development, marketing and project management teams for the same company. Smart in his new

As part of the expansion, OCRC has expanded the existing PK unit to 10,000ft². The unit’s redesigning and extension has added fully secured atrium to the facility. OCRC

The sale facilitates Harvard Drug to market, sell and distribute OTC and nicotine gum products sold under the Rugby trademark and also allows Watson to retain manufacturing, selling

The conference will also discuss the global AD research, which includes improving early detection, proper diagnosis methods, harmonization of imaging techniques across patient populations, identifying factors that affect

The partnership is expected to develop reusable transport packaging solutions that enable pharmaceutical shippers and others to improve cold chain operations management. The technology will provide on-demand data

DHIN, designed for Delaware medical practices, allows members to electronically shares medically relevant information like patient data, clinical results, and reports. Bizmatics CEO Vinay Deshpande said DHIN certification

Patients with advanced solid tumors are being recruited in clinical trials at Harvard University’s Dana-Farber Cancer Institute and partner Beth Israel Deaconess Medical Center. Cellceutix chief scientific officer

The CHF16m ($17m) facility will annually produce about 7,000 tonnes of products including Resource, Isosource and Sustagen, which are designed for managing diabetes, renal disorders and malnutrition. Nestle